Starboard has acquired a $1 billion stake in Pfizer and is seeking changes. Morgan Stanley strategists suggest that positive economic data benefits quality cyclicals due to their resilience to higher yields. The firm has upgraded cyclicals to overweight from neutral based on strong jobs data and expected rate cuts.